These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17398401)

  • 1. Matrix metalloproteinases in peripheral vascular disease.
    Hobeika MJ; Thompson RW; Muhs BE; Brooks PC; Gagne PJ
    J Vasc Surg; 2007 Apr; 45(4):849-57. PubMed ID: 17398401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases in critical limb ischemia.
    Hobeika MJ; Edlin RS; Muhs BE; Sadek M; Gagne PJ
    J Surg Res; 2008 Sep; 149(1):148-54. PubMed ID: 18155249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and abdominal aortic aneurysms: a potential therapeutic target.
    Sinha S; Frishman WH
    J Clin Pharmacol; 1998 Dec; 38(12):1077-88. PubMed ID: 11301559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of matrix metalloproteinases in venous leg ulcers development].
    Bogaczewicz J; Dudek W; Wroński J; Chodorowska G; Przywara S; Krasowska D; Zubilewicz T
    Pol Merkur Lekarski; 2005 Nov; 19(113):686-92. PubMed ID: 16498813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase inhibition therapy for vascular diseases.
    Newby AC
    Vascul Pharmacol; 2012; 56(5-6):232-44. PubMed ID: 22326338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal aortic aneurysm and abdominal wall hernia as manifestations of a connective tissue disorder.
    Antoniou GA; Georgiadis GS; Antoniou SA; Granderath FA; Giannoukas AD; Lazarides MK
    J Vasc Surg; 2011 Oct; 54(4):1175-81. PubMed ID: 21820838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.
    Pradhan-Palikhe P; Vikatmaa P; Lajunen T; Palikhe A; Lepäntalo M; Tervahartiala T; Salo T; Saikku P; Leinonen M; Pussinen PJ; Sorsa T
    Scand J Immunol; 2010 Aug; 72(2):150-7. PubMed ID: 20618774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
    Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
    Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of statins in non-cardiac vascular surgery patients.
    Stalenhoef AF
    J Vasc Surg; 2009 Jan; 49(1):260-5. PubMed ID: 19174265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
    Galis ZS; Khatri JJ
    Circ Res; 2002 Feb; 90(3):251-62. PubMed ID: 11861412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular remodeling and protease inhibition--bench to bedside.
    Sluijter JP; de Kleijn DP; Pasterkamp G
    Cardiovasc Res; 2006 Feb; 69(3):595-603. PubMed ID: 16387286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
    Schmoker JD; McPartland KJ; Fellinger EK; Boyum J; Trombley L; Ittleman FP; Terrien C; Stanley A; Howard A
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):155-61. PubMed ID: 17198804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.